# EirGen Pharma Ltd – FDA Inspection, Feb 9, 2018

Source: https://www.keypedia.com/records/fda_inspections/eirgen-pharma-ltd/38df6883-00ec-43b2-9c16-2cdf1cedbe90
Source feed: FDA_Inspections

> FDA inspection 1044406 of EirGen Pharma Ltd, February 09, 2018. Classification: No Action Indicated (NAI). 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1044406
- Company Name: EirGen Pharma Ltd
- Inspection Date: 2018-02-09
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1276330 - 2023-10-13
- FDA Inspection 1199821 - 2023-01-27
- FDA Inspection 1009392 - 2017-03-03
- FDA Inspection 892754 - 2014-08-15
- FDA Inspection 803013 - 2012-09-14

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/dennis-cantellops-paite/3336bbb8-8520-4a8a-9085-76e7a55ca773)

Company: https://www.keypedia.com/companies/eirgen-pharma-ltd/f9a682ae-b665-4341-814c-af610c74a3ec

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c